Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375187
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-04-16
Brief Title:
Engineering Tumor Infiltrating Lymphocytes Injection GC203 TIL for the Treatment of Advanced Malignant Solid Tumors
Sponsor:
Shanghai Juncell Therapeutics
Organization:
Shanghai Juncell Therapeutics
Organization Data
Organization:
Shanghai Juncell Therapeutics
Class:
INDUSTRY
Study ID:
GC203 TIL-ST-Ⅰ
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Juncell Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None